Time Speaker Subject 9:00 AM – 9:05 AM Peter Marks, CBER OD, FDA

Welcome Remarks

9:05 AM – 9:20 AM Robert Johnson, BARDA

Pandemic preparedness, target product profile, timelines, and the need for continued investment

9:20 AM – 9:35 AM Natalie Thornburg, CDC

Epidemiology, disease burden, continued need for COVID-19 vaccines

9:35 AM – 10:00 AM John Beigel, NIH

Features of novel vaccines, need for next generation vaccines

10:00 AM – 10:20 AM Presentation – Novavax, Inc.
Filip Dubosky, Rick Crowley

Recombinant COVID-19 vaccines

10:20 AM – 10:40 AM

Presentation – Sanofi
Roman Chicz

Recombinant COVID-19 vaccines

10:40 AM – 11:00 AM Presentation – SK bioscience
Harry Kleanthous

Recombinant COVID-19 vaccines

11:00 AM – 11:20 PM Presentation – Dyadic
Mark Emalfarb

Recombinant COVID-19 vaccines

11:20 AM – 11:40 AM Presentation – Biological E, Limited
Vikram Parakdar 

Recombinant COVID-19 vaccines

11:40 AM – 12:00 PM Presentation – Intravacc
Dinja Oosterhoff

Recombinant COVID-19 vaccines

12:00 PM – 12:10 PM Break

Break

12:10 PM – 12:55 PM Frank Arnold, BARDA
Jerry Weir, FDA
Joel Straus, BIO
Dave Robinson, BMGF
Adam Hacker, CEPI

Panel Discussion
Moderated by David Kaslow
“Overcoming challenges to address strain updates and pandemic readiness”.

12:55 PM – 1:00 PM David Kaslow

Closing

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.